|
1.
|
2026/03
|
|
Inhibition of MAFB and PI3K/AKT Signaling for Hereditary FSGS with Multicentric Carpotarsal Osteolysis.
|
|
2.
|
2025/10
|
|
Rituximab-induced long-term remission in childhood-onset, uncomplicated, frequently relapsing or steroid-dependent nephrotic syndrome: a randomized, placebo-controlled trial and a follow-up study.
|
|
3.
|
2025/08
|
|
Description of Patterns in Reduced-Lead Electroencephalography Performed for Suspected Electrographic Seizures in Pediatric Patients With Altered Mental Status Using Standardized Terminology.
|
|
4.
|
2025/07
|
|
A rare case of steroid-resistant nephrotic syndrome complicated by Wernicke's encephalopathy.
|
|
5.
|
2024/12
|
|
Current management for foreign body and toxic agent ingestion in a pediatric primary emergency center.
|
|
6.
|
2024/02
|
|
Factors related to recurrence of proteinuria in childhood IgA nephropathy.
|
|
7.
|
2023/12
|
|
Long-term outcome of combination therapy with corticosteroids, mizoribine and RAS inhibitors as initial therapy for severe childhood IgA vasculitis with nephritis.
|
|
8.
|
2023/10
|
|
Annual patterns in the outcomes and post-arrest care for pediatric out-of-hospital cardiac arrest: A nationwide multicenter prospective registry in Japan.
|
|
9.
|
2023/03
|
|
Application of adult prehospital resuscitation rules to pediatric out of hospital cardiac arrest.
|
|
10.
|
2023/01
|
|
Time course of serum cytokine level changes within 72 h after onset in children with acute encephalopathy and febrile seizures.
|
|
11.
|
2023
|
|
Underestimation of kidney function due to poorly controlled 21-hydroxylase deficiency.
|
|
12.
|
2022/10
|
|
Characteristics of Pediatric Nasal Foreign Body Cases That Required Multiple Removal Procedures: A Single Tertiary Medical Center Cross-Sectional Study.
|
|
13.
|
2022/08
|
|
Use of renin-angiotensin system inhibitors as initial therapy in children with Henoch-Schönlein purpura nephritis of moderate severity.
|
|
14.
|
2022/06
|
|
Efficacy of combination therapy for childhood complicated focal IgA nephropathy.
|
|
15.
|
2022/03
|
|
Growth and differentiation factor-15 as a potential prognostic biomarker for status-epilepticus-associated-with-fever: A pilot study.
|
|
16.
|
2022/03
|
|
Prognostic effects of treatment protocols for febrile convulsive status epilepticus in children.
|
|
17.
|
2022/03
|
|
Target Temperature Management and Survival with Favorable Neurological Outcome After Out-of-Hospital Cardiac Arrest in Children: A Nationwide Multicenter Prospective Study in Japan.
|
|
18.
|
2022/02
|
|
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
|
|
19.
|
2022/01
|
|
Identification of novel OCRL isoforms associated with phenotypic differences between Dent disease-2 and Lowe syndrome.
|
|
20.
|
2021/11
|
|
Moyamoya disease with refractory hypertension associated with peripheral arterial stenosis in the renal parenchyma.
|
|
21.
|
2021/07
|
|
An "old and new" complication in a child with nephrotic syndrome: Answers.
|
|
22.
|
2021/07
|
|
An "old and new" complication in a child with nephrotic syndrome: Questions.
|
|
23.
|
2021/07
|
|
Early steroid pulse therapy for children with suspected acute encephalopathy: An observational study.
|
|
24.
|
2021/05
|
|
Prediction of AESD and neurological sequelae in febrile status epilepticus.
|
|
25.
|
2021/04
|
|
Clinicopathological significance of glomerular capillary IgA deposition in childhood IgA nephropathy.
|
|
26.
|
2021/01
|
|
Elevated cytokine, chemokine, and growth and differentiation factor-15 levels in hemorrhagic shock and encephalopathy syndrome: A retrospective observational study.
|
|
27.
|
2020/12
|
|
A pediatric case of tocilizumab-resistant TAFRO syndrome treated successfully with rituximab.
|
|
28.
|
2020/11
|
|
A rare case of peritonitis in a young woman on peritoneal dialysis.
|
|
29.
|
2020/11
|
|
Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome.
|
|
30.
|
2020/08
|
|
Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
|
|
31.
|
2020/06
|
|
Clinical and genetic variability of PAX2-related disorder in the Japanese population.
|
|
32.
|
2020/06
|
|
Crescentic IgA nephropathy in children.
|
|
33.
|
2020/04
|
|
Detailed characteristics of acute encephalopathy with biphasic seizures and late reduced diffusion: 18-year data of a single-center consecutive cohort.
|
|
34.
|
2020/03
|
|
Poor Long-Term Survival of Out-of-Hospital Cardiac Arrest in Children.
|
|
35.
|
2019/11
|
|
Clinicopathological characteristics and renal outcomes of childhood-onset lupus nephritis with acute kidney injury: A multicenter study.
|
|
36.
|
2019/09
|
|
Clinical characteristics of HNF1B-related disorders in a Japanese population.
|
|
37.
|
2019/09
|
|
Thermal epiglottitis: Acute airway obstruction caused by ingestion of hot food.
|
|
38.
|
2019/08
|
|
Predicting the outcomes of targeted temperature management for children with seizures and/or impaired consciousness accompanied by fever without known etiology.
|
|
39.
|
2019/07
|
|
Location of arrest and survival from out-of-hospital cardiac arrest among children in the public-access defibrillation era in Japan.
|
|
40.
|
2019/05
|
|
Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).
|
|
41.
|
2019/04
|
|
Nonconvulsive Seizure Detection by Reduced-Lead Electroencephalography in Children with Altered Mental Status in the Emergency Department.
|
|
42.
|
2019/02
|
|
Renal-hepatic-pancreatic dysplasia-1 diagnosed on comprehensive gene analysis.
|
|
43.
|
2018/11
|
|
Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
|
|
44.
|
2018/10
|
|
Complement activation associated with ADAMTS13 deficiency may contribute to the characteristic glomerular manifestations in Upshaw-Schulman syndrome.
|
|
45.
|
2018/08
|
|
Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.
|
|
46.
|
2018/08
|
|
Strong Association of the HLA-DR/DQ Locus with Childhood Steroid-Sensitive Nephrotic Syndrome in the Japanese Population.
|
|
47.
|
2018/05
|
|
Development of ultra-deep targeted RNA sequencing for analyzing X-chromosome inactivation in female Dent disease.
|
|
48.
|
2018/01
|
|
Successful Treatment of Transplantation-associated Atypical Hemolytic Uremic Syndrome With Eculizumab.
|
|
49.
|
2017/11
|
|
Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.
|
|
50.
|
2017/03
|
|
IgA nephropathy with presentation of nephrotic syndrome at onset in children.
|
|
51.
|
2017
|
|
Difficult Renal Pathological Classification in a Case of Pediatric Nephrotic Syndrome.
|
|
52.
|
2016/11
|
|
Association between low birth weight and childhood-onset chronic kidney disease in Japan: a combined analysis of a nationwide survey for paediatric chronic kidney disease and the National Vital Statistics Report.
|
|
53.
|
2016/10
|
|
Efficacy of rituximab therapy against intractable steroid-resistant nephrotic syndrome.
|
|
54.
|
2016/05
|
|
Transient hyperphosphatasemia in three pediatric patients treated with cyclosporine.
|
|
55.
|
2016/01
|
|
Insignificant impact of VUR on the progression of CKD in children with CAKUT.
|
|
56.
|
2015/12
|
|
Growth impairment in children with pre-dialysis chronic kidney disease in Japan.
|
|
57.
|
2015/12
|
|
Long-term outcome of childhood IgA nephropathy with minimal proteinuria.
|
|
58.
|
2015/03
|
|
Renal biopsy criterion in idiopathic nephrotic syndrome with microscopic hematuria at onset.
|
|
59.
|
2015/02
|
|
Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy.
|
|
60.
|
2014/10
|
|
16q12 microdeletion syndrome in two Japanese boys.
|
|
61.
|
2014/10
|
|
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
|
|
62.
|
2014/05
|
|
Candidate gene analysis using genomic quantitative PCR: identification of ADAMTS13 large deletions in two patients with Upshaw-Schulman syndrome.
|
|
63.
|
2014/04
|
|
Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort study.
|
|
64.
|
2014/02
|
|
Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.
|
|
65.
|
2013/09
|
|
Pre-dialysis chronic kidney disease in children: results of a nationwide survey in Japan.
|
|
66.
|
2013/01
|
|
Spontaneous remission in children with IgA nephropathy.
|
|
67.
|
2012/08
|
|
Renal biopsy criterion in children with asymptomatic constant isolated proteinuria.
|
|
68.
|
2011/04
|
|
Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity.
|
|
69.
|
2011/01
|
|
Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
|
|
70.
|
2009/12
|
|
Acute renal failure due to obstructive uric acid stones associated with acute gastroenteritis.
|
|
71.
|
2009/05
|
|
Increased chymase-positive mast cells in children with crescentic glomerulonephritis.
|
|
72.
|
2008/06
|
|
Improved renal survival in Japanese children with IgA nephropathy.
|
|
73.
|
2007/11
|
|
Long-term follow-up of juvenile acute nonproliferative glomerulitis (JANG).
|
|
74.
|
2007/07
|
|
OCRL1 mutations in patients with Dent disease phenotype in Japan.
|
|
75.
|
2007/04
|
|
Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
|
|
76.
|
2006/07
|
|
Segmental membranous glomerulonephritis in children: comparison with global membranous glomerulonephritis.
|
|
77.
|
2006/04
|
|
High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.
|
|
78.
|
2006/02
|
|
Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?
|
|
79.
|
2004/08
|
|
Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome.
|
|
80.
|
2004/02
|
|
A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy.
|
|
81.
|
2003/07
|
|
Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.
|
|
82.
|
2002/05
|
|
Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome.
|
|
83.
|
2001/09
|
|
Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome.
|
|
84.
|
2001/05
|
|
Pathophysiology and treatment of IgA nephropathy in children.
|
|
85.
|
2001/04
|
|
Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy.
|
|
86.
|
2000/05
|
|
Genetics of immunoglobulin A nephropathy.
|
|
87.
|
1999/08
|
|
Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy.
|
|
88.
|
1998/12
|
|
Platelet-activating factor acetylhydrolase gene mutation in Japanese nephrotic children.
|
|
89.
|
1998/05
|
|
ACE gene polymorphism in childhood IgA nephropathy: association with clinicopathologic findings.
|
|
90.
|
1995/01
|
|
Internephron heterogeneity of growth factors and sclerosis--modulation of platelet-derived growth factor by angiotensin II.
|
|
91.
|
1995
|
|
Long-term cyclosporin in steroid-dependent nephrotic syndrome.
|
|
92.
|
1994/02
|
|
Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms.
|
|
93.
|
1994
|
|
Internephron heterogeneity of growth factors and sclerosis.
|
|
94.
|
1993/06
|
|
Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome.
|
|
95.
|
1992
|
|
Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats.
|
|
96.
|
1991/09
|
|
Asymptomatic constant isolated proteinuria in children.
|
|
97.
|
1990/09
|
|
Ciclosporin treatment in children with steroid-dependent nephrotic syndrome.
|
|
Display 5 items
|
|
Display all(97)
|
